Valuation: H&R GmbH & Co. KGaA

Market Cap 275M 311M 260M 236M 442M 29.87B 446M 3.12B 1.2B 15.25B 1.17B 1.14B 49.08B P/E 2026 *
5.71x
P/E 2027 * 20x
Enterprise Value 298M 337M 282M 255M 479M 32.35B 483M 3.38B 1.3B 16.52B 1.27B 1.24B 53.17B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.21x
Free-Float
21.97%
Yield 2026 *
0.68%
Yield 2027 * 0.68%
08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-01 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/03/25 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
1 day-0.81%
1 week+0.54%
Current month+8.82%
1 month+8.82%
3 months+51.02%
6 months+80.93%
Current year+72.49%
1 week 7.1
Extreme 7.1
7.46
1 month 6.76
Extreme 6.76
7.46
Current year 3.91
Extreme 3.91
7.46
1 year 3.91
Extreme 3.91
7.46
3 years 3.23
Extreme 3.23
7.46
5 years 3.23
Extreme 3.23
9.56
10 years 3.23
Extreme 3.23
18.88
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%+0.54%+48.89%+53.53% 312M
+0.39%+0.93%+5.30%+27.84% 122B
+3.78%+3.13%+523.74%+270.87% 59.33B
-2.27%-2.32%-23.18%-43.76% 37.94B
-2.51%-4.04%+5.70%-23.39% 32.36B
-0.18%-5.44%+34.35%+56.71% 24.32B
-0.49%-1.94%+18.36%-38.66% 18.82B
-3.21%+1.07%+33.97%+11.25% 19.52B
-2.61%-3.19%+35.48%+297.72% 18.05B
-3.88%+0.14%+175.00%+469.00% 17.71B
Average -1.18%-0.01%+85.76%+108.11% 35.01B
Weighted average by Cap. -0.25%+0.59%+104.60%+90.29%

Financials

2026 *2027 *
Net sales 1.4B 1.58B 1.32B 1.2B 2.24B 152B 2.27B 15.84B 6.1B 77.48B 5.94B 5.81B 249B 1.36B 1.54B 1.29B 1.17B 2.19B 148B 2.21B 15.46B 5.96B 75.64B 5.8B 5.67B 243B
Net income 48.09M 54.49M 45.5M 41.27M 77.36M 5.23B 78.13M 546M 210M 2.67B 205M 200M 8.59B 13.79M 15.62M 13.05M 11.83M 22.18M 1.5B 22.4M 157M 60.32M 766M 58.67M 57.39M 2.46B
Net Debt 22.87M 25.91M 21.64M 19.62M 36.79M 2.49B 37.15M 260M 100M 1.27B 97.3M 95.18M 4.09B 8.65M 9.8M 8.18M 7.42M 13.92M 941M 14.05M 98.19M 37.84M 480M 36.81M 36.01M 1.55B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
29/09/26 €7.400 +0.27% 3,650
28/09/26 €7.380 -0.54% 7,895
25/09/26 €7.420 -0.54% 3,430
24/09/26 €7.460 +0.81% 1,748
23/09/26 €7.400 +0.54% 3,068
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.380EUR
Average target price
7.500EUR
Spread / Average Target
+1.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock